Cholangiocarcinoma Extrahepatic
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma Extrahepatic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors [NA]
A completed clinical trial comparing robotic versus open pancreaticoduodenectomy for pancreatic and periampullary tumors.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma [Phase 1]
Phase 1 trial evaluating PEGPH20 with cisplatin and gemcitabine, with or without atezolizumab, in previously untreated unresectable/metastat…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction [NA]
This ClinicalTrials.gov update notes a completed trial comparing winged perimeter biliary stents to traditional plastic stents for malignant…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer [Phase 1]
Phase 1 study evaluating the safety, tolerability, and preliminary efficacy of a triplet regimen of gemcitabine hydrochloride, oxaliplatin, …
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma [Phase 2]
Phase 2 study of cabozantinib as monotherapy in advanced cholangiocarcinoma completed; results were posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Patients With Biliary Cancer [Phase 2]
A Phase 2 trial of the investigational drug DX-8951f in biliary tract cancers has completed, evaluating extrahepatic cholangiocarcinoma and …